Earnings Day Dominates as Russell Clock Ticks Down

Earnings in Focus

The busiest day of the season is here. Amazon and Intel report Q3 results after the US close, alongside Bristol-Myers Squibb, Gilead Sciences, and Illumina. In Europe, ING Groep, Renault, and Volkswagen all delivered results this morning. ORTEX Alt Data flagged a divergence ahead of those prints. Austrian car registration data runs +6% year-on-year for Renault and -6% for Volkswagen, both datasets measured to lead revenue by roughly 18 to 32 days. Analysts lifted eBay targets today after its Q3 beat, pushing the consensus to $118.40.

Russell Cut-off Today

Tomorrow's close sets the Russell ranking date. Viasat and Twist Bioscience are the names under most pressure. ORTEX Index Rebalance Radar puts VSAT deletion probability at 80%, with $1.3B of forced selling at stake. TWST sits at the same 80% odds, carrying $1.5B across 3.7 days of normal volume. Both need double-digit gains to reach even odds. On the addition side, Health Catalyst (HCAT) sits exactly on the entry line at a $135M market cap. Trade day typically runs at 8.8x normal volume.

Short Sellers and a Nuclear Anomaly

Bears built new positions in Grindr this week, lifting short interest to 20.5% of free float from 13.9% seven days ago. AI chip name Cerebras saw similar moves, climbing from 15.2% to 20.2%. Separately, Southern Company recorded nuclear reactor output 10.0 standard deviations below its own history on 27 October, the sharpest deviation ORTEX has measured in the dataset. Short interest in SO stands at just 2.6% of free float, so the market was not positioned for it.

Europe: MSCI and M&A Watch

The MSCI World November review announcement is due 11 November. Flutter Entertainment carries an 81% deletion probability, with $705M of potential selling. CVC Capital Partners' agreed tender for Italian pharma name Recordati carries an 88% completion probability. A FTSE MIB deletion would follow, forcing an estimated $218M of selling across 11 days of volume.